These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3438260)

  • 1. [Use of glipizide and evaluation of its effect on microcirculation in patients with diabetes mellitus type 2].
    Spesivtseva VG; Golubiatnikova GA; Koroleva TV; Pokryshkin VI; Anisimova VN
    Probl Endokrinol (Mosk); 1987; 33(6):10-3. PubMed ID: 3438260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glipizide on platelet function and fibrinolytic activity.
    Ketsa K; Jererat S; Nitiyanant W; Suwanwattana K
    J Med Assoc Thai; 1987 Oct; 70(10):578-82. PubMed ID: 3694080
    [No Abstract]   [Full Text] [Related]  

  • 3. [A comparative evaluation of the effect of glurenorm and sulfonylurea preparations on the intravascular microcirculatory indices in type-II diabetes mellitus].
    Kakhnovskiĭ IM; Koroleva TV; Zakharchenko VN; Larionov SN
    Probl Endokrinol (Mosk); 1993; 39(2):7-9. PubMed ID: 8016059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical efficacy of a Minidiab preparation (glipizide) in an acute experiment].
    Borisova AM; Taneva T; Koev D; Georgieva R
    Vutr Boles; 1988; 27(2):85-9. PubMed ID: 3137730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Our experience in treating diabetes mellitus with the preparation Minidiab].
    Tsanev A; Lazarov G; Manolov D; Daskalova I; Kolebinov N
    Vutr Boles; 1988; 27(2):89-93. PubMed ID: 3414105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary results of non-insulin dependent diabetes mellitus treated with glipizide].
    Lu JM; Pan CY; Li CF
    Zhonghua Nei Ke Za Zhi; 1988 Mar; 27(3):143-6, 196. PubMed ID: 3219929
    [No Abstract]   [Full Text] [Related]  

  • 7. New perspectives in noninsulin-dependent diabetes mellitus and the role of glipizide in its treatment. Proceedings of a symposium.
    Am J Med; 1983 Nov; 75(5B):1-99. PubMed ID: 6673593
    [No Abstract]   [Full Text] [Related]  

  • 8. Glipizide and glyburide.
    Kure J
    N C Med J; 1986 Mar; 47(3):149-53. PubMed ID: 3083269
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide.
    Tirkkonen T; Heikkilä P; Huupponen R; Laine K
    J Intern Med; 2010 Oct; 268(4):359-66. PubMed ID: 20698928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The second generation sulfonylureas: glipizide and glyburide.
    Baker DE; Campbell RK
    Diabetes Educ; 1985; 11(3):29-36. PubMed ID: 3935402
    [No Abstract]   [Full Text] [Related]  

  • 11. [A comparison between glibenclamide and glipizide in the treatment of type II diabetes].
    Shi MZ; Feng JG; Zheng JJ
    Zhonghua Nei Ke Za Zhi; 1991 Feb; 30(2):94-7, 126. PubMed ID: 1907539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of the second-generation sulfonylurea glipizide.
    Lebovitz HE; Feinglos MN
    Am J Med; 1983 Nov; 75(5B):46-54. PubMed ID: 6369967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of hypoglycemic sulfonylureas on human red blood cell transglutaminase activity.
    Gomis R; Casanovas A; Casamitjana R; Sarto A; Arroyo J; Coves MJ; Rivera F; Vilardell E
    Diabetes Res Clin Pract; 1988 May; 5(1):31-6. PubMed ID: 2900125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and efficacy of glipizide.
    Feinglos MN; Lebovitz HE
    Am J Med; 1983 Nov; 75(5B):60-6. PubMed ID: 6369969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glipizide: a second-generation sulfonylurea hypoglycemic agent. Pharmacology, pharmacokinetics and clinical use.
    Lebovitz HE
    Pharmacotherapy; 1985; 5(2):63-77. PubMed ID: 3923454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glipizide in the treatment of non-insulin-dependent diabetes mellitus].
    Luis Iriarte J
    Rev Clin Esp; 1989 Jun; 185(1):24-32. PubMed ID: 2772334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs.
    Lebovitz HE; Feinglos MN; Bucholtz HK; Lebovitz FL
    J Clin Endocrinol Metab; 1977 Sep; 45(3):601-4. PubMed ID: 903405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis.
    Pantalone KM; Kattan MW; Yu C; Wells BJ; Arrigain S; Jain A; Atreja A; Zimmerman RS
    Diabetes Care; 2010 Jun; 33(6):1224-9. PubMed ID: 20215447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical comparison of glipizide and glyburide.
    Schmitt JK
    Diabetes Care; 1989 Jan; 12(1):39. PubMed ID: 2496963
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduction in use of healthcare services with combination sulfonylurea and rosiglitazone: findings from the Rosiglitazone Early vs SULfonylurea Titration (RESULT) study.
    Herman WH; Dirani RG; Horblyuk R; O'Neill MC; Kravitz B; Heise MA; Bakst A; Freed MI;
    Am J Manag Care; 2005 Apr; 11(4):273-8. PubMed ID: 15839187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.